4.7 Article

Aspirin protects human coronary artery endothelial cells against atherogenic electronegative LDL via an epigenetic mechanism: a novel cytoprotective role of aspirin in acute myocardial infarction

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Endocrinology & Metabolism

Effects of Electronegative VLDL on Endothelium Damage in Metabolic Syndrome

Chu-Huang Chen et al.

DIABETES CARE (2012)

Article Chemistry, Multidisciplinary

Chemical composition-oriented receptor selectivity of L5, a naturally occurring atherogenic low-density lipoprotein

Liang-Yin Ke et al.

PURE AND APPLIED CHEMISTRY (2011)

Article Gastroenterology & Hepatology

Chronic Aspirin Use Suppresses CDH1 Methylation in Human Gastric Mucosa

Tomomitsu Tahara et al.

DIGESTIVE DISEASES AND SCIENCES (2010)

Editorial Material Cardiac & Cardiovascular Systems

Hyperhomocysteinemia and occlusive vascular disease - An emergent role for fibroblast growth factor 2

Miguel Angel Medina

CIRCULATION RESEARCH (2008)

Article Cardiac & Cardiovascular Systems

Deletion of LOX-1 reduces atherogenesis in LDLR knockout mice fed high cholesterol diet

Jawahar L. Mehta et al.

CIRCULATION RESEARCH (2007)

Article Cardiac & Cardiovascular Systems

Aspirin inhibits ox-LDL-mediated LOX-1 expression and metalloproteinase-1 in human coronary endothelial cells

JL Mehta et al.

CARDIOVASCULAR RESEARCH (2004)

Article Pharmacology & Pharmacy

Oxidized low-density lipoprotein inhibits vascular endothelial growth factor-induced endothelial progenitor cell differentiation

T Imanishi et al.

CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY (2003)

Article Medicine, General & Internal

Cyclooxygenase inhibitors and the antiplatelet effects of aspirin.

F Catella-Lawson et al.

NEW ENGLAND JOURNAL OF MEDICINE (2001)

Review Cardiac & Cardiovascular Systems

Aspirin

EH Awtry et al.

CIRCULATION (2000)